Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Accelerating Cervical Cancer Screening With Human Papillomavirus Genotyping.

American journal of preventive medicine - 1 Apr 2023

Sawaya George F, Saraiya Mona, Soman Ashwini, Gopalani Sameer V, Kenney Kristy, Miller Jacqueline

Abstract excerpt

INTRODUCTION: Selective utilization of human papillomavirus (HPV) genotyping in cervical cancer screening can accelerate clinical management, leading to earlier identification and treatment of precancerous lesions and cancer. Specifically, immediate colposcopy (instead of 1-year return) is recommended in persons with normal cytology and HPV genotypes 16 and/or 18, and expedited treatment (instead of colposcopy)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human papillomavirus 16

Share to Human Papillomavirus Viruses

Share to Mass Screening

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 36935166
DOI: 10.1016/j.amepre.2022.10.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Accelerating Cervical Cancer Screening With Human Papillomavirus Genotyping.PMID 36935166Read ↗

The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology.Semantic proximity Read ↗

Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.Semantic proximity Read ↗

Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.Semantic proximity Read ↗

Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.Semantic proximity Read ↗

High-Risk HPV Genotype Distribution According to Cervical Cytology and AgeSemantic proximity Read ↗

A real-world, cross-sectional, and longitudinal study on high-risk human papillomavirus genotype distribution in 31,942 women in Dongguan, China.Semantic proximity Read ↗

High-Risk Human Papillomavirus Prevalence and Genotype Distribution in Two Opportunistic Cervical Screening Periods in Spain: A Tertiary Hospital-Based Study.Semantic proximity Read ↗

Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring GuidelinesSemantic proximity Read ↗

Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system.Semantic proximity Read ↗

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology ResultsSemantic proximity Read ↗

Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesionsSemantic proximity Read ↗

Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.